Yatharth Hospital & Trauma Care Services Ltd - Stock Valuation and Financial Performance

BSE: 543950 | NSE: YATHARTH | Hospital & Healthcare Services | Small Cap

Yatharth Hospital Share Price

662.10 -8.80 -1.31%
as on 31-Oct'24 16:01

DeciZen - make an informed investing decision on Yatharth Hospital

Overall Rating
Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Yatharth Hospital & Trauma Care Services stock performance -

mw4me loader
P/E Ratio (SA):
61.89
Market Cap:
5,664.8 Cr.
52-wk low:
344
52-wk high:
688

Is Yatharth Hospital & Trauma Care Services Ltd an attractive stock to invest in?

1. Is Yatharth Hospital & Trauma Care Services Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Yatharth Hospital & Trauma Care Services Ltd is a good quality company.

2. Is Yatharth Hospital & Trauma Care Services Ltd undervalued or overvalued?

The key valuation ratios of Yatharth Hospital & Trauma Care Services Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Yatharth Hospital & Trauma Care Services Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Yatharth Hospital & Trauma Care Services Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

10 Year X-Ray of Yatharth Hospital:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Yatharth Hospital & Trauma Care Services Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 7.1%9.7%17.9%37.2%37.3%21.1%-
Value Creation
Index
-0.5-0.30.31.81.70.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 102133165299372420436
Sales YoY Gr.-30.3%24.1%81.3%24.4%13%-
Adj EPS 0.40.11.96.49.89.810.7
YoY Gr.--72.7%1466.7%241.5%52.7%-0.2%-
BVPS (₹) 8.58.610.617.126.997.5100.2
Adj Net
Profit
2.90.812.342.164.28492
Cash Flow from Ops. 1923.525.826.825.616-
Debt/CF from Ops. 6.34.844.14.40.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA32.8%36.6%13%
Adj EPS NA85.9%73.3%-0.2%
BVPSNA63%109.6%262.7%
Share Price - - - 84.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
5.21.419.646.544.616.610.8
Op. Profit
Mgn %
19.423.72728.528.628.327.7
Net Profit
Mgn %
2.90.67.514.117.32021
Debt to
Equity
2.221.510.70-
Working Cap
Days
0758697128260235
Cash Conv.
Cycle
0924426188222

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 36.59%

Net Profit is growing at healthy rate in last 3 years 73.27%

Sales growth is good in last 4 quarters at 11.69%

Return on Equity has declined versus last 3 years average to 10.80%

Latest Financials - Yatharth Hospital & Trauma Care Services Ltd.

Standalone Consolidated
TTM EPS (₹) 10.7 14.7
TTM Sales (₹ Cr.) 436 728
BVPS (₹.) 100.2 105.4
Reserves (₹ Cr.) 774 819
P/BV 6.59 6.26
PE 61.89 45.02
From the Market
52 Week Low / High (₹) 344.00 / 687.95
All Time Low / High (₹) 304.00 / 687.95
Market Cap (₹ Cr.) 5,665
Equity (₹ Cr.) 85.9
Face Value (₹) 10
Industry PE 41.2

Management X-Ray of Yatharth Hospital:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.180.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Yatharth Hospital

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales102133165299372420
Operating Expenses 82101120214265301
Manufacturing Costs48505090123148
Material Costs91318282937
Employee Cost 182232575769
Other Costs 71721395746
Operating Profit 20314585106119
Operating Profit Margin (%) 19.4%23.7%27.0%28.5%28.6%28.3%
Other Income 0011214
Interest 7141313106
Depreciation 81514131313
Exceptional Items 000000
Profit Before Tax 63186086113
Tax 325182129
Profit After Tax 3112426484
PAT Margin (%) 2.9%0.6%7.5%14.1%17.3%20.0%
Adjusted EPS (₹)0.40.11.96.49.89.8
Dividend Payout Ratio (%)0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 565669112176837
Share Capital 161616666686
Reserves 39405346111751
Minority Interest000000
Debt1201029685862
Long Term Debt1201029270762
Short Term Debt00415100
Trade Payables121113161112
Others Liabilities 103234735428
Total Liabilities 197202211286326878

Fixed Assets

Gross Block191194204212223248
Accumulated Depreciation44597290102116
Net Fixed Assets146134132122121133
CWIP 000000
Investments 283334474767
Inventories233234
Trade Receivables1318327686143
Cash Equivalents 011213227
Others Assets712103657304
Total Assets 197202211286326878

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 192426272616
PBT 83186086113
Adjustment 11282725216
Changes in Working Capital 2-5-18-49-49-67
Tax Paid -2-20-9-32-36
Cash Flow From Investing Activity -39-8-4-18-9-167
Capex -1-3-3-6-8-34
Net Investments -12-50-130-125
Others -260-100-8
Cash Flow From Financing Activity 21-20-23-7-6241
Net Proceeds from Shares 40000577
Net Proceeds from Borrowing 0-60000
Interest Paid -5-13-12-12-9-4
Dividend Paid 000000
Others 220-1142-332
Net Cash Flow 2-4-111189
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)5.231.4219.6346.4944.5916.58
ROCE (%)7.089.7317.9137.1937.3221.06
Asset Turnover Ratio0.520.670.81.21.210.7
PAT to CFO Conversion(x)6.33242.170.640.410.19
Working Capital Days
Receivable Days4643556680100
Inventory Days876333
Payable Days451320250190171110

Yatharth Hospital & Trauma Care Services Ltd Stock News

Yatharth Hospital & Trauma Care Services Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Yatharth Hospital on 31-Oct-2024 16:01 is ₹662.1.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Oct-2024 16:01 the market cap of Yatharth Hospital stood at ₹5,664.8.
The latest P/E ratio of Yatharth Hospital as of 31-Oct-2024 16:01 is 61.89.
The latest P/B ratio of Yatharth Hospital as of 31-Oct-2024 16:01 is 6.59.
The 52-week high of Yatharth Hospital is ₹688.0 and the 52-week low is ₹344.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Yatharth Hospital is ₹436.4 ( Cr.) .

About Yatharth Hospital & Trauma Care Services Ltd

The company was incorporated as ‘Yatharth Hospital & Trauma Care Services Private Limited’ in Delhi as a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated February 28, 2008, issued by the RoC. Pursuant to a special resolution passed by its Shareholders on November 3, 2021, the company was converted into a public limited company and consequently, the name of the company was changed to ‘Yatharth Hospital & Trauma Care Services Limited’ and a fresh certificate of incorporation dated November 18, 2021 was issued by the RoC.

The company’s hospitals (i.e., Noida Extension Hospital and Greater Noida) are the largest private hospital in the National Capital Region of Delhi (Delhi NCR), respectively, in terms of number of beds in Fiscal 2023. The company operates three super specialty hospitals located in Delhi NCR, i.e., at Noida, Greater Noida and Noida Extension, Uttar Pradesh. Further, it acquired a 305-bedded multi-speciality hospital in Orchha, Madhya Pradesh near Jhansi, Uttar Pradesh (Jhansi-Orchha) which commenced commercial operations in from April 10, 2022, and is one of the largest hospital in Jhansi-Orchha-Gwalior region in terms of number of beds. For better and more focussed patient care, the company has carved out the super specialty as Centres of Excellence (COE) namely Centre of Medicine, Centre of General Surgery, Centre of Cardiology, Centre of Neurosciences, Centre of Nephrology & Urology, Centre of Paediatrics, Centre of Pulmonology, Centre of Gynaecology, and Centre of Orthopaedics & Spine & Rheumatology. Establishing COEs involves equipping these specialties with (i) advanced medical infrastructure; (ii) trained and experienced doctors, nursing, paramedical and other staff; and (iii) resources to provide a better healthcare experience to the patient and attendants. The company’s COEs represent its top 10 revenue-generating specialties. Its COEs are led by a team of respective domain expert doctors who are ably assisted by other doctors in its pursuit of providing better healthcare services to its patients. Further, while it has have started bone marrow and kidney transplant operations at its hospitals located in Noida Extension and Greater Noida, it also intends to introduce new specialties such as radiation therapy to its oncology department at its hospitals located in Noida Extension and Jhansi-Orchha.

The company’s hospitals have been designed to comply with international quality standards. All its hospitals are accredited by the NABH while its hospitals located at Greater Noida and Noida Extension are also accredited by NABL. All of its hospitals offer spacious suites along with modern deluxe and super deluxe rooms, and comfortable patient waiting areas. Its diagnostic areas are designed with the goals of providing patient-friendly, spacious and relaxing environments. It has advanced medical equipment such as Azurion catheterization laboratory, 1.5 Tesla wholebody MRI with optical digital broadband and embedded express coil technology for minimal patient repositioning and advanced non-contrast MR Angiography, 128 slice CT scan, endo bronchial ultrasound, nerve conduction velocity (NCV), advanced surgical equipment including Thulium Uro laser, flexible scope, advance laparoscope, advance microscopes, Cusa set. The advanced equipments provide for better and more accurate diagnosis, as well as insight into the surgical procedure, which increases surgical success rate. Some of its modular operation theatres are equipped with high efficiency particulate air (HEPA) filters and laminar flow, operating microscopes with image intensifiers. Its in-house diagnostic radiology setup and diagnostic labs are well equipped centres with comprehensive diagnostic capabilities including, haematology, biochemistry, microbiology, molecular biology and histopathology along with 24x7 in-house pharmacy shops.

Business area of the company 

The company offers healthcare services across several specialties and super specialties.

Awards, accreditations & recognition

Accreditations

  • 2022: Certificate of hospital grading under the category ‘excellent’ from Infomerics Analytics & Research Pvt Ltd to the Greater Noida Hospital.
  • 2022: Certificate of accreditation from National Accreditation Board for Hospitals & Healthcare Providers to the Jhansi-Orchha Hospital.
  • 2022: Certificate of accreditation (ISO 15189:2012) from National Accreditation Board for Testing and Calibration Laboratories for medical testing for the Noida Extension Hospital.
  • 2021: Certificate of accreditation from National Accreditation Board for Hospitals& Healthcare Providers to the Noida Extension Hospital.
  • 2020: Certificate of accreditation (ISO 15189:2012) from National Accreditation Board for Testing and Calibration Laboratories for molecular testing (RTPCR-Covid 19) for the Noida Extension Hospital.
  • 2017: Certificate of accreditation from National Accreditation Board for Hospitals & Healthcare Providers to the Noida Hospital.
  • 2016: Certificate of accreditation from National Accreditation Board for Hospitals & Healthcare Providers for the Greater Noida Hospital.

Awards

  • 2023: Awarded UP Ratan Samman by Dainik Jagran Inext.
  • 2021: 5 star grading by Infomerics Analysts & Research Private Limited for its hospitals located at Noida, Noida Extension and Greater Noida.
  • 2021: Covid Thank You Award by Niva Bupa.
  • 2021: Certificate of appreciation as ‘Heroes’-Beyond the Call of Duty from Tata Consultancy Services.
  • 2020: Awarded 1st Rank in Swachhta Ranking Competition in the category of Swachh Hospital (for the quarter ended September 2019) in compliance with Swachh Survekshan League 2020 by Noida Authority.
  • 2020: Awarded 1stPrize in Swachhta Ranking Competition in the category of Swachh Hospital (for the quarter ended June 2019) in compliance with Swachh Survekshan League 2020 by Noida Authority.
  • 2020: Recognized as Emerging Hospital Chain in Delhi NCR by Medico Trip India.

History and milestone 

  • 2010: Established its first hospital (i.e., Greater Noida Hospital).
  • 2013: Established its second hospital (i.e., NoidaHospital).
  • 2019: Commenced operations at its third hospital (i.e., Noida Extension Hospital) which was acquired in 2016 pursuant to acquisition of its Subsidiary, AKS.
  • 2022: Acquired fourth hospital (i.e., Jhansi-Orchha Hospital) pursuant to acquisition of its Subsidiary, Ramraja.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.